BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables rises 42.6% from a year ago
Net receivables stood at $3.18M at the end of Q1 FY2026, up 42.6% from a year earlier and up 41.8% from the prior quarter. Over 3 fiscal years it compounded at +45.9% a year.
Context
- Net receivables amounted to 7.0% of total assets at the end of Q1 FY2026, down 1.4 pp from a year earlier.
- Net receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +42.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 2.24M USD
- Year-over-year change
- +67.1%
- 4-year CAGR
- +37.9%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.24M | +67.1% |
| FY2024 | 2024-12-31 | 1.34M | +38.6% |
| FY2023 | 2023-12-31 | 968K | +34.1% |
| FY2022 | 2022-12-31 | 722K | +16.5% |
| FY2021 | 2021-12-31 | 620K | — |
Net Receivables vs competitors
How BHST compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +42.6% is the 5th highest of 8, against a peer median of +49.3%.
- Net receivables amounts to 7.0% of total assets for BHST, versus a peer median of 14.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $329.07M USD | -4.8% | -5.3% | 16.8% | |
| Mar 2026 | $186.71M USD | +8.0% | -0.1% | 28.1% | |
| Mar 2026 | $80.7M USD | +70.0% | +17.8% | 24.0% | |
| Mar 2026 | $61.65M USD | +49.3% | -7.2% | 25.4% | |
| Mar 2026 | $17.57M USD | +120.3% | -24.4% | 9.8% | |
| Mar 2026 | $12.54M USD | -27.1% | -32.9% | 12.2% | |
| Feb 2026 | CA$11.72M CAD | +228.4% | +29.4% | 5.4% | |
| Mar 2026 | $3.18M USD | +42.6% | +45.9% | 7.0% | |
USGOU.S. GoldMining Inc. | Feb 2026 | $29.78K USD | — | — | 0.4% |
| Peer median (excluding BHST) | — | +49.3% | -5.3% | 14.5% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.12M | 1.74M | 5.36M | 2.39M | 23.03M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 620K | 722K | 968K | 1.34M | 2.24M |
| Inventory | 928K | 1.38M | 2.47M | 3.66M | 4.56M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 5.67M | 4.32M | 9.05M | 7.86M | 30.5M |
| Property, Plant & Equipment (Net) | 4.36M | 4.91M | 5.77M | 16.77M | 16.73M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 179K | 163K | 179K | 371K | 433K |
| Total Non-current Assets | 4.54M | 5.07M | 5.95M | 17.15M | 17.17M |
| Total Assets | 10.21M | 9.39M | 15M | 25M | 47.67M |
| Account Payables | 875K | 1.07M | 1.78M | 3.53M | 2.63M |
| Short-term Debt | 0 | 8.55M | 20.53M | 3.91M | 149K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 394K | 836K | 1.3M | 492K |
| Other Current Liabilities | 1.33M | 698K | 1.57M | 3.66M | 2.09M |
| Total Current Liabilities | 2.92M | 11.52M | 26.47M | 14.26M | 7.68M |
| Long-term Debt | 0 | 0 | 0 | 0 | 2.42M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.82M | 2.01M | 0 | 0 | 0 |
| Other Non-current Liabilities | 340K | 123K | 1.96M | 272K | 1.98M |
| Total Non-current Liabilities | 4.43M | 3.8M | 3.39M | 9.41M | 14.53M |
| Total Liabilities | 7.35M | 15.32M | 29.86M | 23.67M | 22.22M |
| Common Stock | 62.56M | 65.01M | 68.65M | 97.75M | 133M |
| Retained Earnings | (59.71M) | (70.94M) | (83.51M) | (96.42M) | (107.55M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.86M | (5.93M) | (14.85M) | 1.33M | 25.45M |
| Total Debt | 2.66M | 10.56M | 22.34M | 13.82M | 14.1M |
| Net Debt | (1.46M) | 8.82M | 16.99M | 11.43M | (8.92M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.